KLRS
Kalaris Therapeutics
KLRS
KLRS
52 hedge funds and large institutions have $24.6M invested in Kalaris Therapeutics in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
35% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 17
Holders
52
Holding in Top 10
1
Calls
$17K
Puts
–
Top Buyers
| 1 | +$279K | |
| 2 | +$232K | |
| 3 | +$190K | |
| 4 |
Squarepoint
New York
|
+$142K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$51.8K |
Top Sellers
| 1 | -$105M | |
| 2 | -$865K | |
| 3 | -$240K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$181K |
| 5 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$176K |